It's time for investors to get back into British pharmaceutical company GSK , according to investor Sarat Sethi.
The Federal Reserve's latest meeting minutes will be a key focal point for investors in the week ahead,
Generac may be a bit too optimistic about its prospects going forward, according to Wells Fargo. Analyst Praneeth
It's time to buy AI-powered fintech stock Pagaya Technologies based on its path to growth, according to Canaccord